Clik here to view.
MM+M debuts the 2024 Agency 100
MM+M today announced the launch of the 2024 Agency 100. The brand’s annual ranking of the top 100 medical marketing agencies of North America is set to publish digitally on June 11 and in the June...
View ArticleClik here to view.
JPM 2024: Pharma CEOs face a crossroads
With the 2024 J.P. Morgan Healthcare Conference underway, MM+M’s Marc Iskowitz provides an update from on the ground in San Francisco. Digital Editor Jack O’Brien talks with Insilico Medicine’s chief...
View ArticleClik here to view.
AI to headline Davos discussion, says Hackensack Meridian CEO
Jack O’Brien discusses what’s on tap at Davos with Hackensack Meridian Health CEO Robert Garrett, who’s chairing the World Economic Forum’s healthcare governance community. Lecia Bushak recaps Roivant...
View ArticleClik here to view.
MM+M launches 2024 MM+M Awards
Now in its 21st year, the medical marketing industry’s premier awards program returns with a handful of new categories and expansions of existing ones. The first entry deadline has been set at April...
View ArticleClik here to view.
Dissecting Walmart’s healthcare strategy with Dr. Wig
Even prior to the COVID-19 pandemic, retail companies such as Walmart have made deliberate, strategic moves to gain a foothold in the healthcare industry. Digital Editor Jack O’Brien interviews Dr....
View ArticleClik here to view.
How did I get here? Initiative’s Michele Sirkin
Michele SirkinHead of HCP, communications designInitiative When Michele Sirkin relocated from New York to Philadelphia, she exchanged national media work on behalf of organizations such as Microsoft...
View ArticleClik here to view.
Elanco’s Jeff Simmons talks launch planning
Elanco’s president/CEO Jeff Simmons tells Marc Iskowitz the animal health firm will ramp up DTC and digital advertising as it enters a “historic” launch phase. Lecia Bushak explains how Sen. Bernie...
View ArticleClik here to view.
Me and My Heart: What the hell was that?
Bill Fitzpatrick, Haymarket Media’s senior producer of podcasts, is a 42-year-old married father of three, an award-winning audio engineer and a long-suffering fan of the New York Mets. Starting in...
View ArticleClik here to view.
Punch the clock: Doctors can’t catch a break
With levels of burnout surging and professional fulfillment plunging in the pandemic’s long wake, it would seem wise to ensure that physicians are allotted more than their share of vacation time to...
View ArticleClik here to view.
Drug shortages in America
February 7, 2024 FDA lists higher doses of Eli Lilly’s Mounjaro on shortage list The FDA has listed 10, 12.5 and 15 mg doses of Eli Lilly’s popular diabetes drug Mounjaro on its drug shortages list. by...
View ArticleClik here to view.
Sanofi’s AI-assisted pipeline strategy, unpacked by R&D lead
Jack O’Brien interviews Sanofi’s global head of R&D portfolio strategy, Helen Merianos, who explains how genAI has “changed the trajectory” of pipeline decisions by the drugmaker. Lecia Bushak...
View ArticleClik here to view.
Me and My Heart: I have what now?
Fresh off an abrupt diagnosis that throws his life into disarray, Bill Fitzpatrick is admitted to the hospital to receive a stent. Fitzpatrick guides the audience into a frantic hospital scene that...
View ArticleClik here to view.
MM+M unveils agenda for Transform: The Patient, Provider and Payer Engagement...
MM+M has unveiled the full agenda for its annual Transform conference. The event, set to take place in New York City on April 3, will explore the intersectionality of three essential constituencies:...
View ArticleClik here to view.
MM+M 40 Under 40 2024 preview: From watching the sky to behavioral sci
With the MM+M 40 Under 40 event taking place this Thursday, Marc Iskowitz speaks with honoree Jazmin Correa as she recounts her journey from typhoon forecaster in the Peace Corps to CX director at...
View ArticleClik here to view.
Me and My Heart: How do I live with this?
Post-hospital discharge, Bill Fitzpatrick adjusts to living with heart disease as he resumes working and trying to maintain a normal life. However, Fitzpatrick’s return to the office is littered with...
View ArticleClik here to view.
Dermavant’s Todd Zavodnick is moving derm into the digital world
Immuno-dermatology, stuck in a “cassette world” of steroid treatments, needs to move to the digital era, according to Dermavant CEO Todd Zavodnick, whose drug Vtama is the first FDA-approved...
View ArticleClik here to view.
Me and My Heart: Raising awareness
In the series finale, Bill Fitzpatrick and Jack O’Brien reflect on their respective heart ailments and hear cardiovascular experts’ thoughts about the future of patient care. A special thanks to the...
View ArticleClik here to view.
MM+M unveils its 2024 Pinnacle Award honorees
MM+M today announced its 2024 Pinnacle Award honorees. The 20 members of this year’s Pinnacle class hail from a diverse range of health and wellness organizations, including pharma companies, medical...
View ArticleClik here to view.
Will generative AI eliminate humans from pharma ads?
Generative AI is here to stay, but what about the human side of medical marketing?Lecia Bushak speaks with Lisa Leonard, a pharma voiceover actor, as well as Jim Kennelly, the owner of Lotas...
View ArticleClik here to view.
Why Xeomin is courting Demi Lovato’s fanbase
Jack O’Brien interviews Merz Aesthetics’ Roberto Casas Rudbeck, VP of U.S. marketing aesthetics, about Xeomin’s choice of Demi Lovato as its latest brand partner. In her Capitol Hill report, Lecia...
View Article
